Global Fund Board Welcomes Final Eighth Replenishment of $12.64 Billion and Supports Strategic Changes to Support Countries on the Path to Self-Reliance – Press Releases

The Global Fund Board welcomes the ultimate eighth replenishment results of $12.64 billion and supports strategic changes to support countries on their path to self-reliance

February 18, 2026

– The Executive Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) welcomed the ultimate final result of the eighth partnership replenishment – ​​USD 12.64 billion – at its 54th meeting on February 12-13.

“This extraordinary result, achieved in a challenging global context, reflects strong support for the Global Fund’s lifesaving mission and its unique partnership model,” said Peter Sands, executive director of the Global Fund. “We are deeply grateful to our co-hosts, South Africa and the UK, our donors and the entire partnership for their tireless support.”

The Board welcomed the broad commitment of the complete partnership to mobilize resources, highlighting the leadership of South Africa and the UK as co-hosts of the eighth replenishment, the driving force of civil society and communities, and the growing contribution of the private sector. At the identical time, the Board emphasized that funding gaps threaten progress within the treatment of the three diseases and noted that efforts to mobilize additional resources will proceed.

Based on the end result, totaling USD 12.64 billion, the Council approved allocations to countries of USD 10.78 billion for the 2027-2029 implementation period, complemented by USD 260 million for catalytic investments. (Decision points [ download in English ]).

These catalytic investments aim to speed up progress in priority areas corresponding to increasing access to modern health products by shaping the market and strengthening regional production capability, thereby amplifying the impact of national subsidies. An additional $306 million from the private sector was committed to catalytic investments. Efforts to mobilize private sector resources are ongoing and expected to further increase the overall financing available for catalytic investments.

Strategic shifts

Given limited resources and significant changes in global health financing, the Council agreed that grant funding can be allocated according to the important thing principle strategic changes introduced by the Global Fund in late 2025 to focus resources on the poorest countries with the best burden of disease and support countries to speed up towards self-reliance as a part of their efforts to finish the three diseases.

“Supporting countries to transition away from Global Fund support is not new; what is new is the scale and pace of the transformation we are currently driving,” Sands said. “We will work with countries to strengthen sustainable development and accelerate their path to self-reliance – supporting, encouraging and ultimately getting out of the way. This means tailored transition pathways for each country, supported by stronger national systems, new sources of financing and continued access to affordable, quality-assured health products. To cope with this new reality, we have developed the strategic changes necessary to ensure transitions that are responsible and rooted in national contexts and priorities.”

Strategic changes will guide countries in the subsequent grant cycle, including:

• Greater priority given to countries with the fewest resources and burdened with the best burdens.
• Defined, predictable transition timeframes adapted to national context, disease burden and economic conditions.
• Optimized use of all available resources through rigorous programmatic prioritization, increased co-financing, market shaping, strengthened integration with national health systems and funding of community-based systems.

“It is our responsibility to lead the partnership through this period of uncertainty in a way that protects sustainability, preserves impact and ensures that the Global Fund continues to benefit the people and communities we serve,” said Lady Roslyn Morauta, Chair of the Global Fund Board. “Decisions on country allocations and catalytic investments – along with key strategic changes to the way we operate – form the financial basis for the new grant cycle.”

“As we look ahead to countries’ journey towards self-reliance, the most impacted and most vulnerable people must remain at the heart of everything we do,” said Bience Gawanas, Vice-Chairman of the Global Fund Board. “Strong social systems and community-led responses are fundamental to sustainable development, and the Board’s strong support for efforts to protect these systems during periods of transition reflects this shared belief.”

Innovation and transformation

Executive Director Peter Sands and the Board of Directors have identified priorities for 2026 and beyond. He stressed the necessity to maximize the impact of each dollar by accelerating equitable access to breakthrough biomedical innovations – highlighting, amongst others, the continued scale-up of the HIV prevention tool lenacapavir as a top priority, in addition to the introduction of modern point-of-care molecular diagnostics for tuberculosis and faster access to alternative first-line treatments and latest malaria vector control tools corresponding to spatial emanators.

In response to current political and economic realities, Sands reaffirmed – with the support of the Board – the Global Fund’s commitment to proceed the transformation by implementing strategic change and playing a proactive and constructive role in shaping a world health ecosystem that’s more collaborative, more coherent and more aware of country and community priorities, drawing on the strengths of its model – particularly its strong market shaping influence, collaborative procurement and civil society and community-led interventions.

The council concluded with a session on ongoing leadership selection processes. The next Chair of the Board and Vice-Chair of the Board will probably be appointed in mid-2026, each serving a three-year term from October 2026 to 2029. The Board will elect the subsequent Executive Director of the Global Fund in October 2026.